P10275 ANDR_HUMAN
Gene name: AR
Protein name: Androgen receptor
List of molecules and drugs that target protein P10275
# | DrugDomain Data | DrugBank Accession | Name | Drug action | Affinity data | InChI Key | SMILES |
---|---|---|---|---|---|---|---|
1 | P10275_DB00255 | DB00255 | Diethylstilbestrol | antagonist | RGLYKWWBQGJZGM-ISLYRVAYSA-N | CC\C(=C(\CC)C1=CC=C(O)C=C1)C1=CC=C(O)C=C1 | |
2 | P10275_DB00367 | DB00367 | Levonorgestrel | binder | WWYNJERNGUHSAO-XUDSTZEESA-N | [H][C@@]12CC[C@@](O)(C#C)[C@@]1(CC)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H] | |
3 | P10275_DB00396 | DB00396 | Progesterone | agonist | Ki(nM) = 8.5 IC50(nM) = 14.0 | RJKFOVLPORLFTN-LEKSSAKUSA-N | [H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C |
4 | P10275_DB00421 | DB00421 | Spironolactone | antagonist | Ki(nM) = 39.4 IC50(nM) = 48.0 EC50(nM) = 20000.0 | LXMSZDCAJNLERA-ZHYRCANASA-N | [H][C@@]12CC[C@@]3(CCC(=O)O3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@@]([H])(CC2=CC(=O)CC[C@]12C)SC(C)=O |
5 | P10275_DB00499 | DB00499 | Flutamide | antagonist | Ki(nM) = 1300.0 IC50(nM) = 154.0 | MKXKFYHWDHIYRV-UHFFFAOYSA-N | CC(C)C(=O)NC1=CC(=C(C=C1)[N+]([O-])=O)C(F)(F)F |
6 | P10275_DB00621 | DB00621 | Oxandrolone | agonist | QSLJIVKCVHQPLV-PEMPUTJUSA-N | [H][C@@]12CC[C@](C)(O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])CC(=O)OC[C@]12C | |
7 | P10275_DB00623 | DB00623 | Fluphenazine | n/a | PLDUPXSUYLZYBN-UHFFFAOYSA-N | OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1 | |
8 | P10275_DB00624 | DB00624 | Testosterone | agonist | Ki(nM) = 3.2 IC50(nM) = 2.7 Kd(nM) = 0.4 EC50(nM) = 1.1 | MUMGGOZAMZWBJJ-DYKIIFRCSA-N | [H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C |
9 | P10275_DB00648 | DB00648 | Mitotane | antagonist | JWBOIMRXGHLCPP-UHFFFAOYSA-N | ClC(Cl)C(C1=CC=C(Cl)C=C1)C1=CC=CC=C1Cl | |
10 | P10275_DB00655 | DB00655 | Estrone | n/a | DNXHEGUUPJUMQT-CBZIJGRNSA-N | [H][C@@]12CCC(=O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3 | |
11 | P10275_DB00665 | DB00665 | Nilutamide | antagonist | IC50(nM) = 9.0 | XWXYUMMDTVBTOU-UHFFFAOYSA-N | CC1(C)NC(=O)N(C1=O)C1=CC(=C(C=C1)[N+]([O-])=O)C(F)(F)F |
12 | P10275_DB00675 | DB00675 | Tamoxifen | n/a | NKANXQFJJICGDU-QPLCGJKRSA-N | CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1 | |
13 | P10275_DB00717 | DB00717 | Norethisterone | agonist | VIKNJXKGJWUCNN-XGXHKTLJSA-N | [H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H] | |
14 | P10275_DB00858 | DB00858 | Drostanolone | agonist | IKXILDNPCZPPRV-RFMGOVQKSA-N | [H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])CC(=O)[C@H](C)C[C@]12C | |
15 | P10275_DB00957 | DB00957 | Norgestimate | partial agonist | KIQQMECNKUGGKA-NMYWJIRASA-N | [H][C@@]12CC[C@@](OC(C)=O)(C#C)[C@@]1(CC)CC[C@]1([H])[C@@]3([H])CC\C(C=C3CC[C@@]21[H])=N/O | |
16 | P10275_DB00984 | DB00984 | Nandrolone phenpropionate | agonist | UBWXUGDQUBIEIZ-QNTYDACNSA-N | [H][C@@]12CC[C@H](OC(=O)CCC3=CC=CC=C3)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H] | |
17 | P10275_DB01026 | DB01026 | Ketoconazole | binder | XMAYWYJOQHXEEK-UHFFFAOYSA-N | CC(=O)N1CCN(CC1)C1=CC=C(OCC2COC(CN3C=CN=C3)(O2)C2=CC=C(Cl)C=C2Cl)C=C1 | |
18 | P10275_DB01063 | DB01063 | Acetophenazine | n/a | WNTYBHLDCKXEOT-UHFFFAOYSA-N | CC(=O)C1=CC=C2SC3=C(C=CC=C3)N(CCCN3CCN(CCO)CC3)C2=C1 | |
19 | P10275_DB01128 | DB01128 | Bicalutamide | antagonist | Ki(nM) = 11.0 IC50(nM) = 10.0 EC50(nM) = 157.0 | LKJPYSCBVHEWIU-UHFFFAOYSA-N | CC(O)(CS(=O)(=O)C1=CC=C(F)C=C1)C(=O)NC1=CC(=C(C=C1)C#N)C(F)(F)F |
20 | P10275_DB01185 | DB01185 | Fluoxymesterone | agonist | Ki(nM) = 5.7 EC50(nM) = 0.3 | YLRFCQOZQXIBAB-RBZZARIASA-N | [H][C@@]12CC[C@](C)(O)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)CC[C@]12C |
21 | P10275_DB01395 | DB01395 | Drospirenone | antagonist | IC50(nM) = 27.0 | METQSPRSQINEEU-HXCATZOESA-N | [H][C@@]12C[C@]1([H])[C@@]1([H])[C@]3([H])[C@]4([H])C[C@]4([H])[C@@]4(CCC(=O)O4)[C@@]3(C)CC[C@]1([H])[C@@]1(C)CCC(=O)C=C21 |
22 | P10275_DB01406 | DB01406 | Danazol | agonist | POZRVZJJTULAOH-LHZXLZLDSA-N | [H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC3=C(C[C@]12C)C=NO3 | |
23 | P10275_DB01420 | DB01420 | Testosterone propionate | agonist | Ki(nM) = 0.25 | PDMMFKSKQVNJMI-BLQWBTBKSA-N | [H][C@@]12CC[C@H](OC(=O)CC)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C |
24 | P10275_DB01428 | DB01428 | Oxybenzone | antagonist | DXGLGDHPHMLXJC-UHFFFAOYSA-N | COC1=CC(O)=C(C=C1)C(=O)C1=CC=CC=C1 | |
25 | P10275_DB01481 | DB01481 | 1-Testosterone | agonist | OKJCFMUGMSVJBG-ABEVXSGRSA-N | [H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])CC(=O)C=C[C@]12C | |
26 | P10275_DB01541 | DB01541 | Boldenone | agonist | RSIHSRDYCUFFLA-DYKIIFRCSA-N | [H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C | |
27 | P10275_DB01564 | DB01564 | Calusterone | n/a | IVFYLRMMHVYGJH-PVPPCFLZSA-N | [H][C@@]12CC[C@](C)(O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@@H](C)CC2=CC(=O)CC[C@]12C | |
28 | P10275_DB01608 | DB01608 | Periciazine | n/a | LUALIOATIOESLM-UHFFFAOYSA-N | OC1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C#N)CC1 | |
29 | P10275_DB01708 | DB01708 | Prasterone | agonist | FMGSKLZLMKYGDP-USOAJAOKSA-N | [H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@@]([H])(O)CC[C@]12C | |
30 | P10275_DB02266 | DB02266 | Flufenamic acid | n/a | IC50(nM) = 50000.0 EC50(nM) = 67000.0 | LPEPZBJOKDYZAD-UHFFFAOYSA-N | OC(=O)C1=CC=CC=C1NC1=CC(=CC=C1)C(F)(F)F |
31 | P10275_DB02901 | DB02901 | Stanolone | n/a | NVKAWKQGWWIWPM-ABEVXSGRSA-N | [H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])CC(=O)CC[C@]12C | |
32 | P10275_DB02932 | DB02932 | (R)-Bicalutamide | n/a | Ki(nM) = 11.0 IC50(nM) = 120.23 | LKJPYSCBVHEWIU-KRWDZBQOSA-N | C[C@](O)(CS(=O)(=O)C1=CC=C(F)C=C1)C(=O)NC1=CC(=C(C=C1)C#N)C(F)(F)F |
33 | P10275_DB02998 | DB02998 | Metribolone | activator | Ki(nM) = 0.4 IC50(nM) = 0.302 Kd(nM) = 0.52 EC50(nM) = 0.013 | CCCIJQPRIXGQOE-XWSJACJDSA-N | [H][C@@]12CC[C@](C)(O)[C@@]1(C)C=CC1=C3CCC(=O)C=C3CC[C@@]21[H] |
34 | P10275_DB04709 | DB04709 | (3AALPHA,4ALPHA,7ALPHA,7AALPHA)- 3A,4,7,7A-TETRAHYDRO-2-(4-NITRO-1-NAPHTHALENYL)-4,7-ETHANO-1H-ISOINDOLE-1,3(2H)-DIONE | n/a | DEJXHCDDTLTVNB-FRVJLOGJSA-N | [H][C@]12C(=O)N(C(=O)[C@@]1([H])[C@]1([H])CC[C@@]2([H])CC1)C1=CC=C(C2=CC=CC=C12)[N+]([O-])=O | |
35 | P10275_DB04839 | DB04839 | Cyproterone acetate | antagonist | Ki(nM) = 14.0 IC50(nM) = 23.0 | UWFYSQMTEOIJJG-FDTZYFLXSA-N | [H][C@@]12C[C@]1([H])[C@@]1(C)C(=CC2=O)C(Cl)=C[C@@]2([H])[C@]3([H])CC[C@](OC(C)=O)(C(C)=O)[C@@]3(C)CC[C@]12[H] |
36 | P10275_DB05234 | DB05234 | LGD2941 | n/a | Ki(nM) = 1.5 EC50(nM) = 7.1 | HWLLYFXDDGGHOE-BCSUUIJWSA-N | C[C@@H]1CC[C@H]([C@@H](O)C(F)(F)F)N1C1=CC2=C(NC(=O)C=C2C(F)(F)F)C=C1 |
37 | P10275_DB06133 | DB06133 | Dimethylcurcumin | inhibitor | ZMGUKFHHNQMKJI-CIOHCNBKSA-N | COC1=CC=C(\C=C\C(\O)=C\C(=O)\C=C\C2=CC(OC)=C(OC)C=C2)C=C1OC | |
38 | P10275_DB06412 | DB06412 | Oxymetholone | agonist | ICMWWNHDUZJFDW-DHODBPELSA-N | [H][C@@]12CC[C@](C)(O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])CC(=O)\C(C[C@]12C)=C/O | |
39 | P10275_DB06710 | DB06710 | Methyltestosterone | agonist | GCKMFJBGXUYNAG-HLXURNFRSA-N | [H][C@@]12CC[C@](C)(O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C | |
40 | P10275_DB06713 | DB06713 | Norelgestromin | partial agonist | ISHXLNHNDMZNMC-XUDSTZEESA-N | [H][C@@]12CC[C@@](O)(C#C)[C@@]1(CC)CC[C@]1([H])[C@@]3([H])CCC(C=C3CC[C@@]21[H])=NO | |
41 | P10275_DB06718 | DB06718 | Stanozolol | agonist | LKAJKIOFIWVMDJ-IYRCEVNGSA-N | [H][C@@]12CC[C@](C)(O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])CC3=NNC=C3C[C@]12C | |
42 | P10275_DB06870 | DB06870 | Tetrahydrogestrinone | n/a | OXHNQTSIKGHVBH-ANULTFPQSA-N | [H][C@@]12CC[C@@](O)(CC)[C@@]1(CC)C=CC1=C3CCC(=O)C=C3CC[C@@]21[H] | |
43 | P10275_DB07039 | DB07039 | (2S)-N-(4-cyano-3-iodophenyl)-3-(4-cyanophenoxy)-2-hydroxy-2-methylpropanamide | n/a | RXSZCFAPSDTELY-SFHVURJKSA-N | C[C@](O)(COC1=CC=C(C=C1)C#N)C(=O)NC1=CC=C(C#N)C(I)=C1 | |
44 | P10275_DB07286 | DB07286 | BMS-564929 | n/a | KEJORAMIZFOODM-PWSUYJOCSA-N | [H][C@@]1(O)CCN2C(=O)N(C(=O)[C@]12[H])C1=C(C)C(Cl)=C(C=C1)C#N | |
45 | P10275_DB07419 | DB07419 | S-23 | n/a | Ki(nM) = 1.7 | SSFVOEAXHZGTRJ-KRWDZBQOSA-N | C[C@](O)(COC1=CC=C(Cl)C(F)=C1)C(=O)NC1=CC(=C(C=C1)C#N)C(F)(F)F |
46 | P10275_DB07421 | DB07421 | 4-{[(1R,2S)-1,2-dihydroxy-2-methyl-3-(4-nitrophenoxy)propyl]amino}-2-(trifluoromethyl)benzonitrile | n/a | INVUBEGZQHQAMY-SJORKVTESA-N | [H][C@](O)(NC1=CC(=C(C=C1)C#N)C(F)(F)F)[C@@](C)(O)COC1=CC=C(C=C1)[N+]([O-])=O | |
47 | P10275_DB07422 | DB07422 | (2S)-2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]-3-(pentafluorophenoxy)propanamide | n/a | MMNRWNREMUMYQG-INIZCTEOSA-N | C[C@](O)(COC1=C(F)C(F)=C(F)C(F)=C1F)C(=O)NC1=CC=C(C(=C1)C(F)(F)F)[N+]([O-])=O | |
48 | P10275_DB07423 | DB07423 | Andarine | n/a | Ki(nM) = 4.0 | YVXVTLGIDOACBJ-SFHVURJKSA-N | CC(=O)NC1=CC=C(OC[C@](C)(O)C(=O)NC2=CC=C(C(=C2)C(F)(F)F)[N+]([O-])=O)C=C1 |
49 | P10275_DB07454 | DB07454 | (R)-3-BROMO-2-HYDROXY-2-METHYL-N-[4-NITRO-3-(TRIFLUOROMETHYL)PHENYL]PROPANAMIDE | n/a | Ki(nM) = 0.3 | QDSWNDMHSBZXKX-JTQLQIEISA-N | C[C@](O)(CBr)C(=O)NC1=CC(=C(C=C1)[N+]([O-])=O)C(F)(F)F |
50 | P10275_DB07717 | DB07717 | (5S,8R,9S,10S,13R,14S,17S)-13-{2-[(3,5-DIFLUOROBENZYL)OXY]ETHYL}-17-HYDROXY-10-METHYLHEXADECAHYDRO-3H-CYCLOPENTA[A]PHENANTHREN-3-ONE | n/a | AJODXHGZHBERGJ-JLYQOUBASA-N | [H][C@]1(O)CC[C@@]2([H])[C@]3([H])CC[C@@]4([H])CC(=O)CC[C@]4(C)[C@@]3([H])CC[C@]12CCOCC1=CC(F)=CC(F)=C1 | |
51 | P10275_DB07769 | DB07769 | S-3-(4-FLUOROPHENOXY)-2-HYDROXY-2-METHYL-N-[4-NITRO-3-(TRIFLUOROMETHYL)PHENYL]PROPANAMIDE | n/a | Ki(nM) = 6.1 | KJMFOTCDISOHDX-INIZCTEOSA-N | C[C@](O)(COC1=CC=C(F)C=C1)C(=O)NC1=CC(=C(C=C1)[N+]([O-])=O)C(F)(F)F |
52 | P10275_DB08035 | DB08035 | 1-TERT-BUTYL-3-(2,5-DIMETHYLBENZYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-AMINE | n/a | QUPXEJURIFFVSX-UHFFFAOYSA-N | CC1=CC=C(C)C(CC2=NN(C3=C2C(N)=NC=N3)C(C)(C)C)=C1 | |
53 | P10275_DB08087 | DB08087 | 4-[(7R,7AS)-7-HYDROXY-1,3-DIOXOTETRAHYDRO-1H-PYRROLO[1,2-C]IMIDAZOL-2(3H)-YL]-1-NAPHTHONITRILE | n/a | NHBIWLQQJPSMNP-CABCVRRESA-N | [H][C@@]1(O)CCN2C(=O)N(C(=O)[C@]12[H])C1=CC=C(C#N)C2=CC=CC=C12 | |
54 | P10275_DB08088 | DB08088 | 2-chloro-4-{[(1R,3Z,7S,7aS)-7-hydroxy-1-(trifluoromethyl)tetrahydro-1H-pyrrolo[1,2-c][1,3]oxazol-3-ylidene]amino}-3-methylbenzonitrile | n/a | Ki(nM) = 0.3 EC50(nM) = 0.2 | KALFKWQLCWAXJO-RNSKTZJQSA-N | N#CC1=CC=C(\N=C2/O[C@@]([H])(C(F)(F)F)[C@]3([H])[C@](O)([H])CCN23)C(C)=C1Cl |
55 | P10275_DB08089 | DB08089 | LGD-2226 | n/a | Ki(nM) = 1.0 EC50(nM) = 0.2 | ULBPQWIGZUGPHU-UHFFFAOYSA-N | FC(F)(F)CN(CC(F)(F)F)C1=CC2=C(NC(=O)C=C2C(F)(F)F)C=C1 |
56 | P10275_DB08461 | DB08461 | 3-[(4-AMINO-1-TERT-BUTYL-1H-PYRAZOLO[3,4-D]PYRIMIDIN-3-YL)METHYL]PHENOL | n/a | QMAIQPBRCNEJAT-UHFFFAOYSA-N | CC(C)(C)N1N=C(CC2=CC(O)=CC=C2)C2=C1N=CN=C2N | |
57 | P10275_DB08604 | DB08604 | Triclosan | n/a | XEFQLINVKFYRCS-UHFFFAOYSA-N | OC1=CC(Cl)=CC=C1OC1=C(Cl)C=C(Cl)C=C1 | |
58 | P10275_DB08804 | DB08804 | Nandrolone decanoate | agonist | JKWKMORAXJQQSR-MOPIKTETSA-N | [H][C@@]12CC[C@H](OC(=O)CCCCCCCCC)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H] | |
59 | P10275_DB08867 | DB08867 | Ulipristal | n/a | HKDLNTKNLJPAIY-WKWWZUSTSA-N | CN(C)C1=CC=C(C=C1)[C@H]1C[C@@]2(C)[C@@H](CC[C@]2(O)C(C)=O)[C@@H]2CCC3=CC(=O)CCC3=C12 | |
60 | P10275_DB08899 | DB08899 | Enzalutamide | inhibitor | Ki(nM) = 17.0 IC50(nM) = 14.0 Kd(nM) = 6520.0 EC50(nM) = 49.0 | WXCXUHSOUPDCQV-UHFFFAOYSA-N | CNC(=O)C1=C(F)C=C(C=C1)N1C(=S)N(C(=O)C1(C)C)C1=CC=C(C#N)C(=C1)C(F)(F)F |
61 | P10275_DB09086 | DB09086 | Eugenol | antagonist | IC50(nM) = 19000.0 | RRAFCDWBNXTKKO-UHFFFAOYSA-N | COC1=C(O)C=CC(CC=C)=C1 |
62 | P10275_DB09123 | DB09123 | Dienogest | antagonist | AZFLJNIPTRTECV-FUMNGEBKSA-N | [H][C@@]12CC[C@@](O)(CC#N)[C@@]1(C)CCC1=C3CCC(=O)C=C3CC[C@@]21[H] | |
63 | P10275_DB09371 | DB09371 | Norethynodrel | n/a | ICTXHFFSOAJUMG-SLHNCBLASA-N | [H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])CC(=O)CC3 | |
64 | P10275_DB09389 | DB09389 | Norgestrel | agonist | WWYNJERNGUHSAO-UHFFFAOYSA-N | CCC12CCC3C(CCC4=CC(=O)CCC34)C1CCC2(O)C#C | |
65 | P10275_DB11064 | DB11064 | Homosalate | antagonist | WSSJONWNBBTCMG-UHFFFAOYSA-N | CC1CC(CC(C)(C)C1)OC(=O)C1=C(O)C=CC=C1 | |
66 | P10275_DB11219 | DB11219 | Enzacamene | antagonist | HEOCBCNFKCOKBX-SDNWHVSQSA-N | CC1=CC=C(\C=C2/C3CCC(C)(C2=O)C3(C)C)C=C1 | |
67 | P10275_DB11425 | DB11425 | Luprostiol | inhibitor | KFUDFIMHDRJVLV-OZCLATTGSA-N | O[C@H](COC1=CC(Cl)=CC=C1)CS[C@@H]1[C@@H](O)C[C@@H](O)[C@H]1C\C=C/CCCC(O)=O | |
68 | P10275_DB11429 | DB11429 | Mibolerone | n/a | PTQMMNYJKCSPET-OMHQDGTGSA-N | [H][C@@]12CC[C@](C)(O)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3C[C@@H](C)[C@@]21[H] | |
69 | P10275_DB11447 | DB11447 | Phenothiazine | n/a | WJFKNYWRSNBZNX-UHFFFAOYSA-N | N1C2=CC=CC=C2SC2=CC=CC=C12 | |
70 | P10275_DB11619 | DB11619 | Gestrinone | antagonist | BJJXHLWLUDYTGC-ANULTFPQSA-N | [H][C@@]12CC[C@@](O)(C#C)[C@@]1(CC)C=CC1=C3CCC(=O)C=C3CC[C@@]21[H] | |
71 | P10275_DB11901 | DB11901 | Apalutamide | antagonist | HJBWBFZLDZWPHF-UHFFFAOYSA-N | CNC(=O)C1=CC=C(C=C1F)N1C(=S)N(C(=O)C11CCC1)C1=CC(=C(N=C1)C#N)C(F)(F)F | |
72 | P10275_DB12499 | DB12499 | Clascoterone | antagonist | GPNHMOZDMYNCPO-PDUMRIMRSA-N | [H][C@@]12CC[C@](OC(=O)CC)(C(=O)CO)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C | |
73 | P10275_DB12941 | DB12941 | Darolutamide | antagonist | BLIJXOOIHRSQRB-PXYINDEMSA-N | C[C@@H](CN1C=CC(=N1)C1=CC=C(C#N)C(Cl)=C1)NC(=O)C1=NNC(=C1)C(C)O | |
74 | P10275_DB13155 | DB13155 | Esculin | agonist | XHCADAYNFIFUHF-TVKJYDDYSA-N | OC[C@H]1O[C@@H](OC2=C(O)C=C3OC(=O)C=CC3=C2)[C@H](O)[C@@H](O)[C@@H]1O | |
75 | P10275_DB13934 | DB13934 | Ligandrol | antagonist | OPSIVAKKLQRWKC-VXGBXAGGSA-N | O[C@H]([C@H]1CCCN1C1=CC=C(C#N)C(=C1)C(F)(F)F)C(F)(F)F | |
76 | P10275_DB13943 | DB13943 | Testosterone cypionate | agonist | HPFVBGJFAYZEBE-ZLQWOROUSA-N | [H][C@@]12CC[C@H](OC(=O)CCC3CCCC3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C | |
77 | P10275_DB13944 | DB13944 | Testosterone enanthate | agonist | VOCBWIIFXDYGNZ-IXKNJLPQSA-N | [H][C@@]12CC[C@H](OC(=O)CCCCCC)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C | |
78 | P10275_DB13946 | DB13946 | Testosterone undecanoate | agonist | UDSFVOAUHKGBEK-CNQKSJKFSA-N | CCCCCCCCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C | |
79 | P10275_DB13951 | DB13951 | Stanolone acetate | n/a | ILCTUFVQFCIIDS-NGFSFWIMSA-N | [H][C@@]12CC[C@H](OC(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])CC(=O)CC[C@]12C | |
80 | P10275_DB14583 | DB14583 | Segesterone acetate | agonist | CKFBRGLGTWAVLG-GOMYTPFNSA-N | [H][C@@]12CC(=C)[C@](OC(C)=O)(C(C)=O)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H] | |
81 | P10275_DB14639 | DB14639 | Boldenone undecylenate | n/a | AHMMSNQYOPMLSX-CNQKSJKFSA-N | C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1CC[C@@H]2OC(=O)CCCCCCCCC=C | |
82 | P10275_DB15488 | DB15488 | Echinacoside | agonist | FSBUXLDOLNLABB-ISAKITKMSA-N | C[C@@H]1O[C@@H](O[C@@H]2[C@@H](O)[C@H](OCCC3=CC(O)=C(O)C=C3)O[C@H](CO[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@H]2OC(=O)\C=C\C2=CC(O)=C(O)C=C2)[C@H](O)[C@H](O)[C@H]1O | |
83 | P10275_DB15647 | DB15647 | Ketodarolutamide | antagonist | GMBPVBVTPBWIKC-NSHDSACASA-N | C[C@@H](CN1C=CC(=N1)C1=CC=C(C#N)C(Cl)=C1)NC(=O)C1=NNC(=C1)C(C)=O |